Sheppard Pratt-Lieber Research Institute, Inc.

Executive Director: Robert Schloesser, M.D.

Research Project Coordinator: Elizabeth M. Postell
410-938-4610 (office)
410-938-4665 (fax)
empostell@sheppardpratt.org

With a shared vision of increasing the possibilities for those with mental illness to live full, productive, and joyful lives, Sheppard Pratt Health System and the Lieber Institute for Brain Development (LIBD) started a new joint venture to translate scientific advances in genetics and brain research into clinical practice. This partnership founded the Sheppard Pratt-Lieber Research Institute, Inc. (SPL), which is now in operation under the leadership of executive director, Robert Schloesser, M.D.

The unprecedented partnership between an internationally renowned care facility for mental illness and a state-of-the art brain research institute creates a new model for speeding the process “from bench to bedside,” or uniting research with clinical care. Infused with an initial $2 million from the founding partners, SPL seeks to develop game-changing new treatments and therapies through research efforts with human patients, including adults with autism, and people with traumatic brain injuries, the study of genetics, the creation of a patient registry with digital records, an extensive biobank, the use of advanced brain imaging technology, and clinical trials for both new and repurposed medications.

SPL is located in newly renovated space on the Towson campus of Sheppard Pratt Health System.